iSpecimen Inc. Proceeds from Common Stock Issued
iSpecimen Inc. (ISPC) reported Proceeds from Common Stock Issued of -$215.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-08-14
- iSpecimen Inc. proceeds from issuance of common stock for the quarter ending 2025-12-31 was $2.25M.
- iSpecimen Inc. proceeds from issuance of common stock for the quarter ending 2025-09-30 was $1.75M.
- iSpecimen Inc. proceeds from issuance of common stock for the quarter ending 2024-12-31 was -$1.10M.
- iSpecimen Inc. proceeds from issuance of common stock for the quarter ending 2024-09-30 was $0.00.
- iSpecimen Inc. proceeds from issuance of common stock for fiscal 2025 was $4.00M, a 903.80% increase from fiscal 2024.
- iSpecimen Inc. proceeds from issuance of common stock for fiscal 2024 was $398.44K.
- iSpecimen Inc. proceeds from issuance of common stock for fiscal 2021 was $2.50M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 9 month as first filed | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$215.00K 10-Q · filed 2026-08-14 | |||||
| 2025-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $4.00M derived: sum of 2 quarters · filed 2026-04-01 | $4.00M 10-K · filed 2026-04-01 | |||
| 2025-09-30 | $1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $1.75M 10-Q · filed 2025-11-17 | ||||
| 2025-06-30 | -$1.10K 10-Q · filed 2026-08-14 | |||||
| 2024-12-31 | -$1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | -$1.10M derived: sum of 2 quarters · filed 2026-04-01 | $259.95K derived: sum of 3 quarters · filed 2026-04-01 | $398.44K 10-K · filed 2026-04-01 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.36M derived: sum of 2 quarters · filed 2024-11-07 | $1.49M 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | $1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $1.49M 10-Q · filed 2024-08-06 | ||||
| 2024-03-31 | $138.49K 10-Q · filed 2025-05-19 | |||||
| 2021-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-30 | -$15.50M derived: sum of 2 quarters · filed 2023-03-30 | $2.50M 10-K/A · filed 2023-03-30 | $18.00M 10-K · filed 2022-03-22 | ||
| 2021-09-30 | -$15.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.50M 10-Q · filed 2022-11-08 | $18.00M 10-Q · filed 2021-11-04 | |||
| 2021-06-30 | $18.00M 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |